Can a once-daily formulation help address treatment challenges in chronic stable angina? In the latest PharmaShots CXO Talks, Jed Litwiniuk, MHA, CEO, Auxilius Pharma, and Uwe Tigör, MD, CMO, Auxilius Pharma, discuss AUX001, a modified-release nicorandil formulation designed to simplify treatment and advance value-added cardiovascular medicines.
AUX001: Rethinking Chronic Stable Angina Treatment
Auxilius Pharma’s lead…
